Hexarelin and Sermorelin are two popular peptides for boosting growth hormone. Find out how they compare in terms of effectiveness, safety, cost, and more.
Hexarelin and sermorelin are both peptide compounds. These peptides have distinct characteristics and mechanisms of action. This article takes a look at both compounds’ properties.
Hexarelin is a synthetic peptide which functions as a growth hormone secretagogue. This synthetic hexapeptide belongs to the growth factor family and demonstrates properties in stimulating growth hormone release[5].
Hexarelin is structurally similar to GHRP-6 [6]. One feature is its stability and controlled impact on appetite, attributed to its minimal effect on ghrelin levels [5].
The peptide's properties include:
Research has shown that hexarelin exhibits binding patterns in the cardiovascular system, with the highest concentrations observed in the ventricles, followed by the atria, aorta, and coronary vessels [8].
The molecular mechanism of hexarelin operates through multiple pathways, demonstrating interaction with various receptor systems. Hexarelin functions primarily by binding to and activating the growth hormone secretagogue receptor (GHS-R) in the brain, similar to its natural counterpart ghrelin [10].
A feature of hexarelin's mechanism is its dual receptor activity. Studies have identified that hexarelin interacts with both GHS-R and CD36, a specific cardiac receptor that mediates its cardiovascular effects [10]. This dual-receptor interaction explains why hexarelin's effects extend beyond simple growth hormone stimulation.
The peptide's effectiveness manifests through several pathways:
Hexarelin may increase coronary perfusion pressure in a dose-dependent manner through CD36 activation [10]. This mechanism explains its observed cardioprotective properties and potential therapeutic applications in cardiovascular health research. The side effects of hexarelin include fluid retention, joint and muscle pain, increased appetite, fatigue, elevated prolactin and cortisol levels, cardiovascular concerns, injection site reactions, hormonal imbalance, metabolic changes, and symptoms like headaches, nausea, and dizziness.
Sermorelin functions as a synthetic analog of growth hormone-releasing hormone (GHRH) [12]. This specialized peptide consists of 29 amino acids, making it the shortest fully functional synthetic fragment of GHRH [12]. Characteristics of sermorelin:
Sermorelin's mechanism mimics the body's natural processes by attaching to specific receptors in the pituitary gland.
Sermorelin may be prescribed to treat growth hormone deficiency in children, and in specific circumstances as determined by a licensed healthcare provider, be prescribed to adults. Sermorelin may support healthy growth hormone levels, muscle enhancement, and improve overall well-being and vitality. The side effects of sermorelin may include injection site reactions (redness, swelling, or pain), headache, flushing, dizziness, nausea, fatigue, sleep disturbances, increased appetite, joint pain, and allergic reactions such as rash or difficulty breathing. Other effects may include overstimulation of growth hormone and cardiovascular and metabolic concerns.
Individual results vary and will determine how fast sermorelin works; please consult your licensed healthcare provider to determine whether you are a suitable candidate for sermorelin therapy and understand specific usages.
As a secretagogue, this synthetic peptide version of Growth Hormone-Releasing Hormone (GHRH) doesn’t directly perform actions but instead prompts the body to release other hormones and compounds [13].
The mechanism involves specific binding to GHRH receptors on the pituitary gland, which triggers an increase in growth hormone production [13]. Key physiological effects:
Sermorelin may be prescribed to children to treat growth hormone deficiency and, in specific circumstances, to adults as determined by a licensed healthcare provider. The side effects of sermorelin may include injection site reactions (redness, swelling, or pain), headache, flushing, dizziness, nausea, fatigue, sleep disturbances, increased appetite, joint pain, and allergic reactions such as rash or difficulty breathing. Other effects may include overstimulation of growth hormone and cardiovascular and metabolic concerns.
A comparison of these growth hormone-releasing peptides reveals differences; understanding these differences may help in evaluating potential applications in research settings.
Sermorelin primarily focuses on the growth hormone-releasing hormone receptor (GHRHR) in the anterior pituitary gland.
Hexarelin peptide demonstrates a significant impact on insulin-like growth factor-I secretion, contributing to enhanced growth velocity [19].
The side effects of sermorelin may include injection site reactions (redness, swelling, or pain), headache, flushing, dizziness, nausea, fatigue, sleep disturbances, increased appetite, joint pain, and allergic reactions such as rash or difficulty breathing. Other effects may include overstimulation of growth hormone and cardiovascular and metabolic concerns.
The side effects of hexarelin include fluid retention, joint and muscle pain, increased appetite, fatigue, elevated prolactin and cortisol levels, cardiovascular concerns, injection site reactions, hormonal imbalance, metabolic changes, and symptoms like headaches, nausea, and dizziness.
Monthly cost of sermorelin treatment may range from $200 to $400 [20]. Treatment plans may involve 25-day supply per month with two days off, as prescribed by a licensed healthcare provider.
While specific pricing varies, its manufacturing process may contribute to its cost structure [19].
Examining the advantages and limitations of these peptides reveals considerations for research applications.
Side effects include:
While both compounds demonstrate effectiveness in stimulating growth hormone release, you must consult a licensed healthcare provider for more details as related to their impacts on your health.
Both compounds may require injection-based delivery, typically through subcutaneous administration [1]. Hexarelin dosage may range from 200-400 mcg daily, while sermorelin may range from 500-1000 mcg daily, as prescribed by a licensed healthcare provider.
Distinct characteristics between hexarelin and sermorelin show different properties.
Hexarelin's broader impact makes it relevant for studies examining rapid GH elevation and cardiovascular function, while sermorelin's controlled approach suits research focused on maintaining physiological hormone patterns. It is pertinent to consult a licensed healthcare provider to learn further about either of these peptides.
Several peptides demonstrate effectiveness for muscle development. These peptides work through different mechanisms:
Please consult a licensed healthcare provider for further information relating to peptide education.
Hexarelin demonstrates characteristics regarding appetite regulation. Research shows that hexarelin does not significantly increase appetite compared to peptides like GHRP-6 [5]. This is due to:
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
1.
MediSearch. Hexarelin vs Sermorelin. Accessed December 5, 2024. https://medisearch.io/share/arAQvhVEPUnN9vgFXvMWLo
2.
Valhalla Vitality. Comparing Hexarelin vs Ipamorelin: Key Differences and Similarities. Published online March 21, 2024. Accessed December 5, 2024. https://valhallavitality.com/blog/comparing-hexarelin-vs-ipamorelin-key-differences-and-similarities
3.
MediSearch. What are the differences in profile between Hexarelin and Sermorelin in terms of therapeutic applications? Accessed December 5, 2024. https://medisearch.io/share/cYPm8qCPEC75GzQ8CFM4YL
5.
Particle Peptides. WHAT IS HEXARELIN? Published online January 19, 2019. Accessed December 5, 2024. https://particlepeptides.com/en/blog/news/what-is-hexarelin
6.
Laron Z. Hexarelin - an overview. Hormones, Brain and Behavior. Accessed December 5, 2024. https://www.sciencedirect.com/topics/nursing-and-health-professions/hexarelin
7.
Cao JM. Hexarelin - an overview. Growth Hormone Secretagogues. Accessed December 5, 2024. https://www.sciencedirect.com/topics/medicine-and-dentistry/hexarelin
8.
Berlanga-Acosta J, Abreu-Cruz A, Herrera DGDB, et al. Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects. Clinical Medicine Insights Cardiology. 2017;11:1179546817694558-1179546817694558. https://pubmed.ncbi.nlm.nih.gov/28469491/
9.
Trainer PJ, Besser GM, Grossman AB, et al. The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine Vasopressin. The Journal of Clinical Endocrinology & Metabolism. 1999;84(7). https://academic.oup.com/jcem/article-abstract/84/7/2489/2864389
10.
Mao Y, Tokudome T, Kishimoto I. The cardiovascular action of hexarelin. Journal of geriatric cardiology : JGC. 2014;11(3):253-258. https://pmc.ncbi.nlm.nih.gov/articles/PMC4178518/
11.
Argiolas A, Melis MR. Hexarelin - an overview. Progress in Neurobiology. Accessed December 5, 2024. https://www.sciencedirect.com/topics/neuroscience/hexarelin
12.
Furman BL. Sermorelin - an overview. xPharm: The Comprehensive Pharmacology Reference. https://www.sciencedirect.com/topics/medicine-and-dentistry/sermorelin
13.
Wellspring Medical. Hormones/Peptides. Published online March 6, 2024. Accessed December 5, 2024. https://wellspringmedicalspa.com/hormones-peptides
14.
Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical interventions in aging. 2006;1(4):307-308. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/
15.
Walker RF. Sermorelin: A better approach to management of adult-onset growth hormone insufficiency? Clin Interv Aging. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/
16.
Askinazi O. Sermorelin Therapy Benefits, Uses, Side Effects, Risks, More. Published online August 21, 2023. Accessed December 5, 2024. https://www.healthline.com/health/sermorelin
17.
Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sexual medicine reviews. 2018;6(1):45-53. https://www.sciencedirect.com/science/article/pii/S205005211730032X?via%3Dihub
18.
Regen Doctors. Sermorelin Peptide Price. Accessed December 5, 2024. https://regendoctors.com/products/sermorelin-peptide-therapy-2000-mcg
19.
Daniskova G. Hexarelin vs Sermorelin: Comparing The Two Peptides. Accessed December 5, 2024. https://medisearch.io/blog/hexarelin-vs-sermorelin
20.
Eden. Sermorelin Cost Per Month: 2024 Pricing Guide & Factors. Accessed December 5, 2024. https://www.tryeden.com/post/sermorelin-monthly-cost-guide-2024
21.
Prime Aesthetica. Sermorelin Injections Benefits. Published online October 14, 2022. Accessed December 5, 2024. https://www.primeaesthetica.com/blog/sermorelin-injections.html
22.
Valhalla Vitality. Understanding the Side Effects of Hexarelin. Published online December 19, 2023. Accessed December 5, 2024. https://valhallavitality.com/blog/understanding-the-side-effects-of-hexarelin
24.
Evolve Healthcare. What Are the Best Peptides for Muscle Growth? Published online July 16, 2024. Accessed December 5, 2024. https://evolvehealthcare.com/what-are-the-best-peptides-for-muscle-growth
25.
Bresciani E, Pitsikas N, Tamiazzo L, et al. Feeding behavior during long-term hexarelin administration in young and old rats. Journal of Endocrinological Investigation. 2008;31(7):647-652. https://link.springer.com/article/10.1007/BF03345618
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
.webp)
